TY - JOUR A1 - El-Helou, Sabine M. A1 - Biegner, Anika-Kerstin A1 - Bode, Sebastian A1 - Ehl, Stephan R. A1 - Heeg, Maximilian A1 - Maccari, Maria E. A1 - Ritterbusch, Henrike A1 - Speckmann, Carsten A1 - Rusch, Stephan A1 - Scheible, Raphael A1 - Warnatz, Klaus A1 - Atschekzei, Faranaz A1 - Beider, Renata A1 - Ernst, Diana A1 - Gerschmann, Stev A1 - Jablonka, Alexandra A1 - Mielke, Gudrun A1 - Schmidt, Reinhold E. A1 - Schürmann, Gesine A1 - Sogkas, Georgios A1 - Baumann, Ulrich H. A1 - Klemann, Christian A1 - Viemann, Dorothee A1 - Bernuth, Horst von A1 - Krüger, Renate A1 - Hanitsch, Leif G. A1 - Scheibenbogen, Carmen M. A1 - Wittke, Kirsten A1 - Albert, Michael H. A1 - Eichinger, Anna A1 - Hauck, Fabian A1 - Klein, Christoph A1 - Rack-Hoch, Anita A1 - Sollinger, Franz M. A1 - Avila, Anne A1 - Borte, Michael A1 - Borte, Stephan A1 - Fasshauer, Maria A1 - Hauenherm, Anja A1 - Kellner, Nils A1 - Müller, Anna H. A1 - Ülzen, Anett A1 - Bader, Peter A1 - Bakhtiar, Shahrzad A1 - Lee, Jae-Yun A1 - Heß, Ursula A1 - Schubert, Ralf A1 - Wölke, Sandra A1 - Zielen, Stefan A1 - Ghosh, Sujal A1 - Laws, Hans-Juergen A1 - Neubert, Jennifer A1 - Oommen, Prasad T. A1 - Hönig, Manfred A1 - Schulz, Ansgar A1 - Steinmann, Sandra A1 - Klaus, Schwarz A1 - Dückers, Gregor A1 - Lamers, Beate A1 - Langemeyer, Vanessa A1 - Niehues, Tim A1 - Shai, Sonu A1 - Graf, Dagmar A1 - Müglich, Carmen A1 - Schmalzing, Marc T. A1 - Schwaneck, Eva C. A1 - Tony, Hans-Peter A1 - Dirks, Johannes A1 - Haase, Gabriele A1 - Liese, Johannes G. A1 - Morbach, Henner A1 - Foell, Dirk A1 - Hellige, Antje A1 - Wittkowski, Helmut A1 - Masjosthusmann, Katja A1 - Mohr, Michael A1 - Geberzahn, Linda A1 - Hedrich, Christian M. A1 - Müller, Christiane A1 - Rösen-Wolff, Angela A1 - Roesler, Joachim A1 - Zimmermann, Antje A1 - Behrends, Uta A1 - Rieber, Nikolaus A1 - Schauer, Uwe A1 - Handgretinger, Rupert A1 - Holzer, Ursula A1 - Henes, Jörg A1 - Kanz, Lothar A1 - Boesecke, Christoph A1 - Rockstroh, Jürgen K. A1 - Schwarze-Zander, Carolynne A1 - Wasmuth, Jan-Christian A1 - Dilloo, Dagmar A1 - Hülsmann, Brigitte A1 - Schönberger, Stefan A1 - Schreiber, Stefan A1 - Zeuner, Rainald A1 - Ankermann, Tobias A1 - Bismarck, Philipp von A1 - Huppertz, Hans-Iko A1 - Kaiser-Labusch, Petra A1 - Greil, Johann A1 - Jakoby, Donate A1 - Kulozik, Andreas E. A1 - Metzler, Markus A1 - Naumann-Bartsch, Nora A1 - Sobik, Bettina A1 - Graf, Norbert A1 - Heine, Sabine A1 - Kobbe, Robin A1 - Lehmberg, Kai A1 - Müller, Ingo A1 - Herrmann, Friedrich A1 - Horneff, Gerd A1 - Klein, Ariane A1 - Peitz, Joachim A1 - Schmidt, Nadine A1 - Bielack, Stefan A1 - Groß-Wieltsch, Ute A1 - Classen, Carl F. A1 - Klasen, Jessica A1 - Deutz, Peter A1 - Kamitz, Dirk A1 - Lassy, Lisa A1 - Tenbrock, Klaus A1 - Wagner, Norbert A1 - Bernbeck, Benedikt A1 - Brummel, Bastian A1 - Lara-Villacanas, Eusebia A1 - Münstermann, Esther A1 - Schneider, Dominik T. A1 - Tietsch, Nadine A1 - Westkemper, Marco A1 - Weiß, Michael A1 - Kramm, Christof A1 - Kühnle, Ingrid A1 - Kullmann, Silke A1 - Girschick, Hermann A1 - Specker, Christof A1 - Vinnemeier-Laubenthal, Elisabeth A1 - Haenicke, Henriette A1 - Schulz, Claudia A1 - Schweigerer, Lothar A1 - Müller, Thomas G. A1 - Stiefel, Martina A1 - Belohradsky, Bernd H. A1 - Soetedjo, Veronika A1 - Kindle, Gerhard A1 - Grimbacher, Bodo T1 - The German national registry of primary immunodeficiencies (2012-2017) JF - Frontiers in Immunology N2 - Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs. Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel. Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1-25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0-88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE-syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%-subcutaneous; 29%-intravenous; 1%-unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy. Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment. KW - registry for primary immunodeficiency KW - primary immunodeficiency (PID) KW - German PID-NET registry KW - PID prevalence KW - European Society for Immunodeficiencies (ESID) KW - IgG substitution therapy KW - CVID Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-226629 VL - 10 ER - TY - JOUR A1 - Brandt, Alexander U. A1 - Zimmermann, Hanna A1 - Kaufhold, Falko A1 - Promesberger, Julia A1 - Schippling, Sven A1 - Finis, David A1 - Aktas, Orhan A1 - Geis, Christian A1 - Ringelstein, Marius A1 - Ringelstein, E. Bernd A1 - Hartung, Hans-Peter A1 - Paul, Friedemann A1 - Kleffner, Ilka A1 - Dörr, Jan T1 - Patterns of Retinal Damage Facilitate Differential Diagnosis between Susac Syndrome and MS JF - PLoS One N2 - Susac syndrome, a rare but probably underdiagnosed combination of encephalopathy, hearing loss, and visual deficits due to branch retinal artery occlusion of unknown aetiology has to be considered as differential diagnosis in various conditions. Particularly, differentiation from multiple sclerosis is often challenging since both clinical presentation and diagnostic findings may overlap. Optical coherence tomography is a powerful and easy to perform diagnostic tool to analyse the morphological integrity of retinal structures and is increasingly established to depict characteristic patterns of retinal pathology in multiple sclerosis. Against this background we hypothesised that differential patterns of retinal pathology facilitate a reliable differentiation between Susac syndrome and multiple sclerosis. In this multicenter cross-sectional observational study optical coherence tomography was performed in nine patients with a definite diagnosis of Susac syndrome. Data were compared with age-, sex-, and disease duration-matched relapsing remitting multiple sclerosis patients with and without a history of optic neuritis, and with healthy controls. Using generalised estimating equation models, Susac patients showed a significant reduction in either or both retinal nerve fibre layer thickness and total macular volume in comparison to both healthy controls and relapsing remitting multiple sclerosis patients. However, in contrast to the multiple sclerosis patients this reduction was not distributed over the entire scanning area but showed a distinct sectorial loss especially in the macular measurements. We therefore conclude that patients with Susac syndrome show distinct abnormalities in optical coherence tomography in comparison to multiple sclerosis patients. These findings recommend optical coherence tomography as a promising tool for differentiating Susac syndrome from MS. KW - optical coherence tomography KW - vasculopathy KW - artery occlusion KW - hearing loss KW - microangiopathy KW - brain KW - endotheliopathy KW - antibodies KW - multiple-sclerosis KW - retinocochleocerebral Y1 - 2012 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-134013 VL - 7 IS - 6 ER - TY - JOUR A1 - Welker, Armin A1 - Kersten, Christian A1 - Müller, Christin A1 - Madhugiri, Ramakanth A1 - Zimmer, Collin A1 - Müller, Patrick A1 - Zimmermann, Robert A1 - Hammerschmidt, Stefan A1 - Maus, Hannah A1 - Ziebuhr, John A1 - Sotriffer, Christoph A1 - Schirmeister, Tanja T1 - Structure‐Activity Relationships of Benzamides and Isoindolines Designed as SARS‐CoV Protease Inhibitors Effective against SARS‐CoV‐2 JF - ChemMedChem N2 - Inhibition of coronavirus (CoV)‐encoded papain‐like cysteine proteases (PL\(^{pro}\)) represents an attractive strategy to treat infections by these important human pathogens. Herein we report on structure‐activity relationships (SAR) of the noncovalent active‐site directed inhibitor (R)‐5‐amino‐2‐methyl‐N‐(1‐(naphthalen‐1‐yl)ethyl) benzamide (2 b), which is known to bind into the S3 and S4 pockets of the SARS‐CoV PL\(^{pro}\). Moreover, we report the discovery of isoindolines as a new class of potent PL\(^{pro}\) inhibitors. The studies also provide a deeper understanding of the binding modes of this inhibitor class. Importantly, the inhibitors were also confirmed to inhibit SARS‐CoV‐2 replication in cell culture suggesting that, due to the high structural similarities of the target proteases, inhibitors identified against SARS‐CoV PL\(^{pro}\) are valuable starting points for the development of new pan‐coronaviral inhibitors. KW - antiviral agents KW - computational chemistry KW - drug design KW - protease inhibitors KW - structure-activity relationships Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-225700 VL - 16 IS - 2 SP - 340 EP - 354 ER - TY - JOUR A1 - Mühlberg, Eric A1 - Umstätter, Florian A1 - Domhan, Cornelius A1 - Hertlein, Tobias A1 - Ohlsen, Knut A1 - Krause, Andreas A1 - Kleist, Christian A1 - Beijer, Barbro A1 - Zimmermann, Stefan A1 - Haberkorn, Uwe A1 - Mier, Walter A1 - Uhl, Philipp T1 - Vancomycin-lipopeptide conjugates with high antimicrobial activity on vancomycin-resistant enterococci JF - Pharmaceuticals N2 - Multidrug-resistant bacteria represent one of the most important health care problems worldwide. While there are numerous drugs available for standard therapy, there are only a few compounds capable of serving as a last resort for severe infections. Therefore, approaches to control multidrug-resistant bacteria must be implemented. Here, a strategy of reactivating the established glycopeptide antibiotic vancomycin by structural modification with polycationic peptides and subsequent fatty acid conjugation to overcome the resistance of multidrug-resistant bacteria was followed. This study especially focuses on the structure–activity relationship, depending on the modification site and fatty acid chain length. The synthesized conjugates showed high antimicrobial potential on vancomycin-resistant enterococci. We were able to demonstrate that the antimicrobial activity of the vancomycin-lipopeptide conjugates depends on the chain length of the attached fatty acid. All conjugates showed good cytocompatibility in vitro and in vivo. Radiolabeling enabled the in vivo determination of pharmacokinetics in Wistar rats by molecular imaging and biodistribution studies. An improved biodistribution profile in comparison to unmodified vancomycin was observed. While vancomycin is rapidly excreted by the kidneys, the most potent conjugate shows a hepatobiliary excretion profile. In conclusion, these results demonstrate the potential of the structural modification of already established antibiotics to provide highly active compounds for tackling multidrug-resistant bacteria. KW - antibiotics KW - multidrug-resistant bacteria KW - enterococci KW - vancomycin KW - structural modification KW - fatty acids KW - polycationic peptides Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-205879 SN - 1424-8247 VL - 13 IS - 6 ER - TY - JOUR A1 - Umstätter, Florian A1 - Werner, Julia A1 - Zerlin, Leah A1 - Mühlberg, Eric A1 - Kleist, Christian A1 - Klika, Karel D. A1 - Hertlein, Tobias A1 - Beijer, Barbro A1 - Domhan, Cornelius A1 - Zimmermann, Stefan A1 - Ohlsen, Knut A1 - Haberkorn, Uwe A1 - Mier, Walter A1 - Uhl, Philipp T1 - Impact of linker modification and PEGylation of vancomycin conjugates on structure-activity relationships and pharmacokinetics JF - Pharmaceuticals N2 - As multidrug-resistant bacteria represent a concerning burden, experts insist on the need for a dramatic rethinking on antibiotic use and development in order to avoid a post-antibiotic era. New and rapidly developable strategies for antimicrobial substances, in particular substances highly potent against multidrug-resistant bacteria, are urgently required. Some of the treatment options currently available for multidrug-resistant bacteria are considerably limited by side effects and unfavorable pharmacokinetics. The glycopeptide vancomycin is considered an antibiotic of last resort. Its use is challenged by bacterial strains exhibiting various types of resistance. Therefore, in this study, highly active polycationic peptide-vancomycin conjugates with varying linker characteristics or the addition of PEG moieties were synthesized to optimize pharmacokinetics while retaining or even increasing antimicrobial activity in comparison to vancomycin. The antimicrobial activity of the novel conjugates was determined by microdilution assays on susceptible and vancomycin-resistant bacterial strains. VAN1 and VAN2, the most promising linker-modified derivatives, were further characterized in vivo with molecular imaging and biodistribution studies in rodents, showing that the linker moiety influences both antimicrobial activity and pharmacokinetics. Encouragingly, VAN2 was able to undercut the resistance breakpoint in microdilution assays on vanB and vanC vancomycin-resistant enterococci. Out of all PEGylated derivatives, VAN:PEG1 and VAN:PEG3 were able to overcome vanC resistance. Biodistribution studies of the novel derivatives revealed significant changes in pharmacokinetics when compared with vancomycin. In conclusion, linker modification of vancomycin-polycationic peptide conjugates represents a promising strategy for the modulation of pharmacokinetic behavior while providing potent antimicrobial activity. KW - glycopeptide antibiotics KW - antimicrobial resistance KW - vancomycin KW - polycationic peptides KW - linker influence KW - pharmacokinetics KW - PEGylation Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-255197 SN - 1424-8247 VL - 15 IS - 2 ER - TY - THES A1 - Zimmermann, Christian T1 - Halbleiterlaser mit lateralem Rückkopplungsgitter für metrologische Anwendungen T1 - Semiconductor lasers with lateral feedback for metrological applications N2 - In der vorliegenden Arbeit wurde angestrebt, die Eigenschaften komplexgekoppelter DFB-Laser bezüglich ihrer Nutzung für metrologische Untersuchungen zu analysieren und zu verbessern. Hierfür wurden die räumlichen Emissionseigenschaften der lateral komplexgekoppelten DFB-Laser in ausgiebigen Studien diskutiert. Für kommerziell erhältliche Laser wurde daraufhin das Fernfeld sowohl in lateraler als auch vertikaler Richtung berechnet. Die entsprechenden Fernfeldmessungen konnten die Theorie bestätigen und wie erwartet, waren die Divergenzwinkel mit 52° FWHM in der Wachstumsrichtung und 12° FWHM in lateraler Richtung (vgl. Abb. 6.4 und 6.5) sehr unterschiedlich und zeugen von einer großen Differenz in den Fernfeldwinkeln. Mit Überlegungen zu dem optischen bzw. elektrischen Einschlusspotential im Hinblick auf die veränderte Fernfeldsituation wurde zunächst die reine Halbleiterlaserschichtfolge optimiert. Der Divergenzwinkel in Wachstumsrichtung wurde um mehr als 50% auf 25° FWHM gesenkt. Damit konnte die Asymmetrie des Fernfeldes um einen Faktor von mehr als 4 reduziert werden. Strahlgüteuntersuchungen zeigten ein nahezu beugungsbegrenztes Gaußsches Strahlprofil in der langsamen Achse mit einem M2-Wert von 1,13 (Abb. 6.3). Eine weitere Untersuchung betraf die Linienbreitenabhängigkeit solcher Laser von ihrer Ausgangsleistung, der Resonatorlänge, der Facettenvergütung und der Gitterkopplung. Die erste Beobachtung betraf die Verschmälerung der Linienbreite mit ansteigender Ausgangsleistung bis hin zu einer erneuten Verbreiterung (Rebroadening) der Linienbreite (siehe Abb. 7.3). Der Einfluss auf die Linienbreite durch eine Veränderung der Resonatorlänge ließ sich sehr gut mit der Theorie vergleichen und so erbrachte eine Verdopplung der Resonatorlänge eine Verschmälerung der Linienbreite um mehr als einen Faktor 3. Die Verlängerung der Kavität begünstigte den negativen Effekt des sog. Rebroadenings nicht, da bei der verwendeten Technologie der lateral komplexen Kopplung der Index-Beitrag an der Rückkopplung sehr klein ist. Im Falle reiner Indexkopplung wäre dies durch die veränderte κ · L-Lage deutlich zu spüren. Ein weiterer, oben auch angesprochener Vorteil der komplexen Kopplung ist, dass die Facettenreflektivitäten einen wesentlich kleineren Einfluss auf die DFB-Ausbeute und auf deren Eigenschaften haben als bei der reinen Indexkopplung. Dies lässt sich ausnutzen, um die Photonenlebensdauer in der Kavität zu erhöhen ohne negativ die DFB-Ausbeute zu beeinflussen. In dieser Arbeit wurde bei verschiedenen Längen die reine gebrochene Facette mit einer vergüteten verglichen und der Einfluss auf die Linienbreite analysiert. Die Frontfacette wurde durch eine Passivierung bei ca. 30% gehalten und die Rückfacette durch einen doppelten Reflektor auf ca. 85% gesetzt. Daraus resultierte eine Reduktion der Linienbreite um mehr als die Hälfte. Neben diesen Ergebnissen wurde auch der Einfluss der komplexen Kopplung untersucht. Da die durch das Gitter zusätzlich eingebrachten Verluste zu einer Vergrößerung der Linienbreiten beitragen, wird bei einem größeren geometrischen Gitterüberlapp das Frequenzrauschen auch entsprechend steigen. Dies ließ sich auch im Experiment bestätigen. Zudem wurde eine Längenabhängigkeit dieses Effektes festgestellt. Die Reduzierung der Linienbreite bei längeren Bauteilen ist deutlich ausgeprägter als bei kürzeren. So ist bei ähnlicher Verringerung des Gitterüberlappes bei einem 900 μm langen Bauteil eine Linienbreitenreduzierung um einen Faktor von „nur“ 1,85 beobachtbar, aber bei der doppelten Kavitätslänge ist dieser Faktor schon auf 3,60 angestiegen. Im Rahmen dieser Arbeit wurden DFB-Laser hergestellt, die eine Linienbreite von bis zu 198 kHz aufwiesen. Dies stellt für lateral komplexgekoppelte Laser einen absoluten Rekordwert dar. Im Vergleich zu Index-DFB-Lasern ist dieser Wert bzgl. der Linienbreite mit den aktuellsten Ergebnissen aus der Forschung zu vergleichen [CTR+11], bei welchen eine Linienbreite zu 200 kHz bestimmt wurde. In dem letzten Abschnitt dieser Arbeit wurde der Einfluss einer veränderten Phasenlage von Gitter und Facette untersucht. Dabei wurden spezielle Bauteile hergestellt (3-Segment-DFB-Laser) und verschiedene Gitterlängen untersucht. Die Phasenlage kann reversibel über den eingestellten Strom in den gitterfreien Segmenten geregelt werden. Wie vorhergesagt, bestätigen die Experimente, dass diese Phasenbeziehung einen signifikanten Einfluss auf die Ausgangsleistung, die Wellenlänge mit ihrer zugehörigen Seitenmodenunterdrückung und auch auf die Linien-breite hat. Bei der Analyse der Linienbreite konnte eindeutig beobachtet werden, dass für die verschiedenen Längen die inverse Linienbreite sehr gut mit der relativen Seitenmodenunterdrückung gekoppelt ist. Dies stellt eine deutliche Erleichterung der zukünftigen Optimierung der komplexgekoppelten DFB-Laser dar, da eine Linienbreitenuntersuchung meist deutlich zeitaufwendiger ist als eine Analyse mit einem optischen Spektrometer. N2 - The goal of this thesis was to analyze and improve the characteristics of complex-coupled DFB-lasers due to their use for metrological investigations. For this purpose, the spatial properties of the laterally complex-coupled DFB-lasers were discussed in extensive studies. It has been explained why the asymmetry of the far field for this special type of laser diode is typically quite high due to the required coupling strength. For commercially available lasers, the far field was calculated in both lateral and vertical direction. The corresponding far field measurements proofed the theory, and as expected, the divergence angles of 52° FWHM in the epitaxial direction and 12° FWHM in lateral direction (see fig. 6.4 and 6.5) showed very huge differences and confirmed the predicted high far field asymmetry. The layer stack was optimized first with regard to the optical and electrical confinement potential to change the far field situation. The far field in the epitaxial direction has been reduced by more than 50% to a value of 25° FWHM. As a result, the asymmetry of the far field could be reduced by a factor of more than 4. Beam profile measurements showed a nearly diffraction limited Gaussian beam profile in the slow axis with a M2-value of 1.13 (fig. 6.3). Additional investigations were done to determine the dependency between the linewidth of such lasers and their optical output power, resonator length, facet reflectivity and grating coupling strength. The first study was related to the narrowing of the linewidth due to the increased optical output power ending up in a rebroadening (compare fig. 7.3). The influence of the resonator length to the linewidth was very close to theory and thus a doubling of the resonator length led to a linewidth narrowing of more than factor 3. Increasing the cavity length did not favour the negative effect of the so-called rebroadening since the portion of index coupling within the used lateral complex-coupling technology is very small. In case of pure index coupling the influence due to the changed κ·L-condition would be increased. A further advantage of the complex-coupling mentioned above is the fact that the influence of the facet reflectivities on the DFB yield and laser characteristics is significantly smaller compared to pure index coupling. This can be used to increase the photon lifetime in the cavity without decreasing the DFB yield. The influence on the linewidth of as-cleaved facets was compared to coated ones with lasers of different length. The front facet was passivated to hold the as-cleaved reflectivity of about 30%, and the rear facet was coated with a layer stack to end up at about 85% reflectivity. The linewidth was more than halved. In addition to these results, the influence of complex-coupling was also investigated. As extra losses are introduced by the grating itself, the frequency noise, produced by a higher geometric overlap of the grating with the lasing mode will rise. This could also be confirmed in the experiment. It was also observed that this effect has a length driven component. Narrowing the linewidth by reducing the grating overlap has a higher influence on a longer device compared to shorter laser diodes. A factor of 1.85 on a 900 μm long device has been observed, but diodes with doubled length showed a factor of 3.60. Within the scope of this thesis, DFB-lasers were produced showing linewidths down to 198 kHz. Regarding complex-coupled laser diodes, this value for the linewidth is an absolute record. Compared to index-coupled DFB-lasers, this value matches to latest research findings [CTR+11]. In the last chapter of this work the influence of the phasing of grating and facet was discussed. Special laser diodes (3-segment DFB-lasers) with different grating lengths were produced. The phasing was determined by the injection current of the grating-free segments. As predicted, the experimental results proved the significant influence of the phasing to output power, wavelength including SMSR and the linewidth. It was also observed that for different lengths the inverse linewidth is proportional to the SMSR. This relationship could be used for improved and faster optimization of complex-coupled DFB-lasers as an investigation of the linewidth is typically more complex than a simple analysis on an optical spectrometer. KW - DFB-Laser KW - Metrologie KW - komplexe Gitterkopplung KW - Linienbreite KW - Atomuhr Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-159618 ER - TY - JOUR A1 - Schuster, Sarah A1 - Lisack, Jaime A1 - Subota, Ines A1 - Zimmermann, Henriette A1 - Reuter, Christian A1 - Mueller, Tobias A1 - Morriswood, Brooke A1 - Engstler, Markus T1 - Unexpected plasiticty in the life cycle of Trypanosoma brucei JF - eLife N2 - African trypanosomes cause sleeping sickness in humans and nagana in cattle. These unicellular parasites are transmitted by the bloodsucking tsetse fly. In the mammalian host’s circulation, proliferating slender stage cells differentiate into cell cycle-arrested stumpy stage cells when they reach high population densities. This stage transition is thought to fulfil two main functions: first, it auto-regulates the parasite load in the host; second, the stumpy stage is regarded as the only stage capable of successful vector transmission. Here, we show that proliferating slender stage trypanosomes express the mRNA and protein of a known stumpy stage marker, complete the complex life cycle in the fly as successfully as the stumpy stage, and require only a single parasite for productive infection. These findings suggest a reassessment of the traditional view of the trypanosome life cycle. They may also provide a solution to a long-lasting paradox, namely the successful transmission of parasites in chronic infections, despite low parasitemia. KW - trypanosoma KW - sleeping sickness KW - tsetse fly KW - transmission KW - life cycle KW - development Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-261744 VL - 10 ER - TY - JOUR A1 - Umstätter, Florian A1 - Domhan, Cornelius A1 - Hertlein, Tobias A1 - Ohlsen, Knut A1 - Mühlberg, Eric A1 - Kleist, Christian A1 - Zimmermann, Stefan A1 - Beijer, Barbro A1 - Klika, Karel D. A1 - Haberkorn, Uwe A1 - Mier, Walter A1 - Uhl, Philipp T1 - Vancomycin Resistance Is Overcome by Conjugation of Polycationic Peptides JF - Angewandte Chemie International Edition N2 - Multidrug‐resistant bacteria represent one of the biggest challenges facing modern medicine. The increasing prevalence of glycopeptide resistance compromises the efficacy of vancomycin, for a long time considered as the last resort for the treatment of resistant bacteria. To reestablish its activity, polycationic peptides were conjugated to vancomycin. By site‐specific conjugation, derivatives that bear the peptide moiety at four different sites of the antibiotic were synthesized. The most potent compounds exhibited an approximately 1000‐fold increased antimicrobial activity and were able to overcome the most important types of vancomycin resistance. Additional blocking experiments using d‐Ala‐d‐Ala revealed a mode of action beyond inhibition of cell‐wall formation. The antimicrobial potential of the lead candidate FU002 for bacterial infection treatments could be demonstrated in an in vivo study. Molecular imaging and biodistribution studies revealed that conjugation engenders superior pharmacokinetics. KW - antibiotics KW - bacterial resistance KW - glycopeptide antibiotics KW - peptide conjugates KW - vancomycin Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-215550 VL - 59 IS - 23 SP - 8823 EP - 8827 ER - TY - JOUR A1 - Zimmermann, Henriette A1 - Subota, Ines A1 - Batram, Christopher A1 - Kramer, Susanne A1 - Janzen, Christian J. A1 - Jones, Nicola G. A1 - Engstler, Markus T1 - A quorum sensing-independent path to stumpy development in Trypanosoma brucei JF - PLoS Pathogens N2 - For persistent infections of the mammalian host, African trypanosomes limit their population size by quorum sensing of the parasite-excreted stumpy induction factor (SIF), which induces development to the tsetse-infective stumpy stage. We found that besides this cell density-dependent mechanism, there exists a second path to the stumpy stage that is linked to antigenic variation, the main instrument of parasite virulence. The expression of a second variant surface glycoprotein (VSG) leads to transcriptional attenuation of the VSG expression site (ES) and immediate development to tsetse fly infective stumpy parasites. This path is independent of SIF and solely controlled by the transcriptional status of the ES. In pleomorphic trypanosomes varying degrees of ES-attenuation result in phenotypic plasticity. While full ES-attenuation causes irreversible stumpy development, milder attenuation may open a time window for rescuing an unsuccessful antigenic switch, a scenario that so far has not been considered as important for parasite survival. KW - Trypanosoma KW - hyperexpression techniques KW - parasitic cell cycles KW - cloning KW - cell cycle and cell division KW - cell differentiation KW - tetracyclines KW - parasitic diseases Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-158230 VL - 13 IS - 4 ER -